While AERS is a powerful tool, it has several limitations. One major issue is underreporting, as not all adverse events are reported, which can lead to an incomplete picture of a product's safety profile. There is also the challenge of causality assessment, as the system relies on reported associations, not confirmed causations. Moreover, the data may be subject to reporting biases, where more severe or unusual events are more likely to be reported than common or expected ones.
